Drew Moghanaki: A critical report from Amsterdam demonstrates misdiagnosed drug-related pneumonitis

Drew Moghanaki, Professor, Chief of Thoracic Oncology at UCLA Department of Radiation Oncology, recently shared on X/Twitter:

“A critical report from Amsterdam demonstrates how often drug-related pneumonitis can be misdiagnosed in patients receiving thoracic radiation therapy. When it occurs, it can lead to premature termination of life-prolonging checkpoint inhibitors.

Access to radiation therapy treatment plans can make all the difference when trying to determine whether radiographic abnormalities on surveillance CT scans represent a harbinger of symptomatic drug-induced pneumonitis versus just an asymptomatic remnant of beam tracks.”

Read further.

Source: Drew Moghanaki/X